New biomarker may help in detecting gliomas, reports Neurosurgery

Marker called ELTD1 reflects new blood vessel formation associated with brain cancers

2013-01-16

(Press-News.org) Philadelphia, Pa. (January 16, 2013) – Researchers using sophisticated genetic testing techniques have identified a promising new biomarker for diagnosis of glioma—the most common type of malignant brain tumor, reports the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

The biomarker ELTD1 "may serve as an additional biomarker for gliomas in preclinical and clinical diagnosis of gliomas," according to the study by Rheal A. Towner of Oklahoma Medical Research Foundation, Oklahoma City.

Biomarker Reflects Rapid Blood Vessel Development Dr. Towner and colleagues used advanced "data mining and bioinformatic" techniques to evaluate genes and gene products potentially associated with gliomas. Glioma is a general term referring to tumors originating in the glial cells of the brain and spinal cord. Gliomas make up about 40 percent of all brain tumors and 80 percent of central nervous system cancers. Especially for advanced (high-grade) gliomas such as glioblastoma multiforme (GBM), expected survival is very poor.

Out of nearly 200 possible markers analyzed, ELTD1 was identified as the strongest candidate for a significant association with glioma. There's special interest in ELTD1 because it is linked to development of new blood vessels, or angiogenesis—a characteristic of rapidly growing cancers. (ELTD1 stands for "epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1.")

Studies in human patients suggested that ELTD1 was strongly associated with gliomas. ELTD1 was more highly expressed in specimens from 50 patients with high-grade gliomas, compared to 21 patients with lower-grade gliomas.

Higher levels of ELDT1 expression were associated with a higher grade of glioma, and with lower survival. ELTD1 compared well with other known markers of glioma, such as vascular endothelial growth factor. It also appeared to be associated with one specific subtype of GBM (mesenchymal GBM).

In further experiments, the researchers transplanted glioma cells into the brains of rats. As the tumors developed, they showed elevated levels of ELTD1, compared to normal brain tissue. The rat studies included evaluation of a "molecular MRI technique" for measuring ELDT1 levels in the living brain.

A Helpful Marker for Glioma Diagnosis? Even with modern treatments, GBM and other malignant gliomas are devastating cancers. In recent years, advances in research have led to the identification of biomarkers associated with glioma. Dr. Towner and colleagues write, "Validation of more biomarkers for GBM could be beneficial in the diagnosis and therapeutic intervention of this disease."

With further study, ELTD1 could become a useful new marker of glioma, including GBM. Gliomas show increased expression of ELTD1, and higher levels of ELTD1 expression are associated with higher tumor grade and a worse prognosis. "Any increase in ELTD1 will more than likely be associated with increased angiogenesis or neovascularization [new blood vessel development] in gliomas," the researchers write.

Although the findings are only preliminary, Dr. Towner and coauthors suggest that ELTD1 could be useful in detecting the presence and grade of gliomas—particularly high-grade gliomas such as GBM. They conclude, "[T]his biomarker may play an important diagnostic role in addition to currently used markers for gliomas, particularly as a histological marker for identifying vascular proliferation."

### About Neurosurgery Neurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world's most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable.

About Lippincott Williams & Wilkins Lippincott Williams & Wilkins (LWW) is a leading international publisher of trusted content delivered in innovative ways to practitioners, professionals and students to learn new skills, stay current on their practice, and make important decisions to improve patient care and clinical outcomes. LWW is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).

ELSE PRESS RELEASES FROM THIS DATE:

Promising new finding for therapies to treat persistent seizures in epileptic patients

2013-01-16

LOS ANGELES (Jan. 16, 2013) – In a promising finding for epileptic patients suffering from persistent seizures known as status epilepticus, researchers reported today that new medication could help halt these devastating seizures. To do so, it would have to work directly to antagonize NMDA receptors, the predominant molecular device for controlling synaptic activity and memory function in the brain. "Despite the development of new medications to prevent seizures, status epilepticus remains a life-threatening condition that can cause extensive brain damage in the patients ...

Using snail teeth to improve solar cells and batteries

2013-01-16

RIVERSIDE, Calif. (www.ucr.edu) — An assistant professor at the University of California, Riverside's Bourns College of Engineering is using the teeth of a marine snail found off the coast of California to create less costly and more efficient nanoscale materials to improve solar cells and lithium-ion batteries. The most recent findings by David Kisailus, an assistant professor of chemical and environmental engineering, details how the teeth of chiton grow. The paper was published today (Jan. 16) in the journal Advanced Functional Materials. It was co-authored by several ...

Developed new method to diagnose hereditary breast and ovarian cancer

2013-01-16

Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on mass sequencing of BRCA1 and BRCA2 genes. The model is based on a genetic and bioinformatic analysis which has been proved very effective. The new protocol has been described in an article published in the European Journal of Human Genetics. In recent years, new advances in sequencing techniques have involved the development of new platforms for nucleic ...

Dynamic Motivational Author, Speaker & Veteran Deborah L. Parker Keynotes Leesburg Virginia's Martin Luther King March & Program, "Moving the Dream Forward For All of Us" January 21

2013-01-16

Deborah L. Parker remembers the evening of April 4, 1968. In her rural Waverly Virginia home with no indoor plumbing, on the way to the laundromat with her mother, it seemed as if the world stopped. The headline of the evening news: Dr. Martin Luther King Jr. has been assassinated. What happens to the dream? Deborah wondered. She was poor, black, and a good student in a segregated Sussex County. Her mother was a single parent of four and they lived with her maternal grandparents in a shotgun style house on a wooded back road. But her mother was determined and her grandparents ...

Migraine with aura may lead to heart attack, blood clots for women

2013-01-16

SAN DIEGO – Women who have migraines with aura, which are often visual disturbances such as flashing lights, may be more likely to have problems with their heart and blood vessels, and those on newer contraceptives may be at higher risk for blood clots, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The first study showed that migraine with aura is a strong contributor to the development of major cardiovascular events such as heart attack and stroke. The Women's ...

Higher quality rating for Medicare Advantage plan linked with increased likelihood of enrollment

2013-01-16

CHICAGO – In a study that included nearly 1.3 million Medicare beneficiaries who were either first-time enrollees or enrollees switching plans, researchers found a positive association between enrollment and publicly reported Medicare Advantage star ratings reflecting plan quality, according to a study appearing in the January 16 issue of JAMA. "To inform enrollment decisions and spur improvement in the Medicare Advantage marketplace, the U.S. Centers for Medicare & Medicaid Services (CMS) provides star ratings reflecting Medicare Advantage plan quality. A combined Part ...

Transmission of tangles in Alzheimer's mice provides more authentic model of tau pathology

2013-01-16

PHILADELPHIA – Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs) comprised of pathological tau filaments. Tau tangles are also found in progressive supranuclear palsy, cortical basal degeneration and other related tauopathies, including chronic traumatic encephalopathy due to repetitive traumatic brain injuries sustained in sports or on the battle field. By using synthetic fibrils made from pure recombinant protein, Penn ...

Tracing the impact of amyloid beta in mild cognitive impairment

2013-01-16

The amount of amyloid β (Aβ) in the brains of people with mild cognitive impairment (MCI) is contributing to early memory loss, and increases with severity of symptoms, finds a study in BioMed Central's open access journal Alzheimer's Research & Therapy. The non-invasive study which used 18F-florbetaben to find Aβ plaques in brain scans to also show that in MCI the affect of Aβ on memory loss is independent of other aspects of mental decline. Positron emission tomography (PET) has previously relied on carbon-11 labeling of Aβ, however this ...

Cutting down on sugar has a small but significant effect on body weight

2013-01-16

Research: Dietary sugars and body weight: a systematic review and meta-analyses of randomised controlled trials and cohort studies Editorial: Science souring on sugar Feature: Sugar and the heart: old ideas revisited Reducing sugar intake has a small but significant effect on body weight in adults, finds a paper published on bmj.com today. Although the effect is relatively small (an average reduction of 0.8 kg), the findings provide some support for international guidelines to cut sugar intake to less than 10% of total energy to help reduce the global obesity epidemic. Excessive ...

Blood clots and artery blockage more likely during IVF pregnancies

2013-01-16

Research: Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study In vitro fertilization (IVF) is associated with an increased risk of pulmonary embolism (blockage of the main artery of the lung) and venous thromboembolism (blood clots) during the first trimester of pregnancy, a study published today on bmj.com suggests. IVF has been used since 1978 for the 10% of couples worldwide affected by infertility. Approximately five million individuals have so far been born after IVF. It is well known that the ...

New biomarker may help in detecting gliomas, reports Neurosurgery

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: